Health ❯ Neurology

Multiple Sclerosis

Symptoms Patient Care Risk Factors Cognitive Performance Prevalence Treatment Methods Inflammation Treatment Estrogen Treatment Options Therapeutic Approaches Cell Biology Prodromal Phase Clinical Research Chronic Spontaneous Urticaria Clinical Development Cannabis Use Brain Function Research Disease Progression Drug Applications Diagnosis Disease Prevention Cognition

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Roche’s global scale will accelerate Phase 3 testing to advance the BTK degrader toward wider patient use.

Study Links Early Menopause to Higher Dementia Risk as HRT Use Correlates With Lower Risk

Largest Study Finds Menopause Does Not Accelerate Disability in Women With MS